Table 5.

Clinical features and immunohistochemical results of the 15 borderline tumors

Tu-mor no.	Sex	Age (years)	Tumor size (cm)	Tumor weight (g)	Tumor Lacation	Clinical symptom	Weiss score	MiR483-3p	IGF2	Smad-4	MIB-1	Follow-up
1	F	55	6	82	Left	No	3	E	N	N	L	Relapse, DOD after 47 m
2	M	49	5	70	Right	Cushing syndrome	3	E	E	E	L	NED after 90 m
3	F	27	9	85	Left	No	3	E	E	N	H	Metastases, DOD after 17 m
4	F	26	5	33	Right	No	3	E	E	E	L	NED after 58 m
5	F	44	3	7	Right	Cushing syndrome	3	E	E	N	L	Relapse, DOD after 25 m
6	F	29	4	27	Right	No	3	N	N	E	L	NED after 45 m
7	M	40	2	2	Right	No	2	N	E	N	L	NED after 100 m
8	M	58	4.5	30	Left	No	2	N	N	N	H	LTFU
9	M	56	10	90	Left	No	2	E	N	N	L	LTFU
10	F	52	5	23	Right	No	2	N	E	E	L	NED after 99 m
11	F	23	3	11	Left	Primary aldosterone sydrome	2	N	N	E	H	LTFU
12	F	52	3	12	Right	No	2	N	E	E	L	NED after 84 m
13	F	59	7	125	Left	No	2	N	N	N	L	NED after 61 m
14	F	56	5	64	Right	Primary aldosterone syndrome	2	E	N	E	H	LTFU
15	F	45	3	20	Left	No	2	N	N	E	L	NED after 53 m

NED, No evidence of disease; DOD, dead of disease; LTFU, lost to follow-up; E, elevated; N, negative/low; H, high, >5%; L, low, <5%.